Nudging COVID-19 Vaccine Uptake by Changing the Default: A Randomized Controlled Trial

Med Decis Making. 2022 Aug;42(6):837-841. doi: 10.1177/0272989X221101536. Epub 2022 Jun 6.

Abstract

Background: Although vaccination against SARS-CoV-2 is considered the central strategy against the pandemic, uptake lags behind target rates.

Method: To explore whether this rate could be enhanced by a nudging strategy that exploits the status quo bias, we conducted a randomized controlled trial in northern Italy comparing vaccination acceptance among 2000 adults, ages 50 to 59 years, who were either invited to set an appointment (opt-in group) or assigned an individual appointment (opt-out group).

Results: Results indicate a difference of 3.2 percentage points, which represents a 32% relative increase in the vaccination rate for the opt-out group compared with the opt-in group.

Conclusions: A significant portion of those who remain unvaccinated may not hold strong beliefs against vaccination but rather tend to inaction and may therefore be nudged toward vaccination with a reduction of action required.

Highlights: Reluctant adults (50-59 years), who had not yet received vaccines against COVID-19, were sent letters announcing appointment availabilityIn an RCT, the status quo option in the notices influenced the rate of vaccine acceptanceNudging via pre-scheduled appointments encouraged vaccine uptake more than invitations to schedule didSwitching the default option yielded a 32% relative increase (13.1% vs. 9.9%) in vaccination.

Keywords: COVID-19; default option; nudging; status quo bias; vaccination; vaccine hesitancy.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Middle Aged
  • Pandemics / prevention & control
  • SARS-CoV-2
  • Vaccination
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines